<DOC>
	<DOCNO>NCT02035332</DOCNO>
	<brief_summary>The primary objective study evaluate use Aurora Ablation System reduce menstrual blood loss 12 month post-treatment . The occurrence adverse event assess along assessment reduction uterine bleeding measure pictorial blood loss assessment chart ( PBLAC ) menstrual diary .</brief_summary>
	<brief_title>A Two-Phase Clinical Study Minerva AURORA Ablation System</brief_title>
	<detailed_description />
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>1 . Refractory menorrhagia definable organic cause ( abnormal uterine bleeding ) 2 . Female subject age 35 50 year 3 . Uterine sound measurement 6.0cm 10.0cm ( external o internal fundus ) 4 . A minimum PBLAC score &gt; 150 3 month prior study enrollment ; OR , A minimum PBLAC score &gt; 150 one month woman either 1. least 3 prior month document fail medical therapy ; 2. contraindication medical therapy ; 3. refuse medical therapy 5 . Premenopausal enrollment determine FSH measurement â‰¤ 40 IU/ml 6 . Not pregnant desire conceive time 7 . Patient agree use hormonal contraception medical intervention bleeding study 8 . Able provide write informed consent use form approve review IRB/EC 9 . Subject agree followup exam data collection , include ability accurately use menstrual diary 10 . Subject literate demonstrate understanding use menstrual diary 1 . Pregnancy subject desire conceive 2 . Complex endometrial hyperplasia confirm histology 3 . Presence active endometritis 4 . Active pelvic inflammatory disease 5 . Active sexually transmit disease ( STD ) 6 . Presence bacteremia , sepsis , active systemic infection 7 . Active infection genitals , vagina , cervix , uterus urinary tract time procedure 8 . Known/suspected gynecological malignancy within past 5 year 9 . Known clot defect bleed disorder 10 . Untreated/unevaluated cervical dysplasia 11 . Known/suspected abdominal/pelvic cancer 12 . Prior uterine surgery ( except low segment cesarean section ) interrupt integrity uterine wall ( e.g. , transmural myomectomy classical cesarean section ) 13 . Previous endometrial ablation procedure 14 . Currently medication could thin myometrial muscle , longterm steroid use 15 . Currently anticoagulants 16 . Abnormal obstruct cavity confirm hysteroscopy SIS , specifically : 1 . Septate bicornuate uterus congenital malformation uterine cavity 2 . Pedunculated submucosal myoma distort uterine cavity 3 . Polyps likely cause subject 's menorrhagia 4 . Intramural subserosal myoma distort uterine cavity 17 . Presence intrauterine device ( IUD ) 18 . Subject currently hormonal birth control therapy unwilling use nonhormonal birth control postablation . 19 . Any general health condition , opinion Investigator , could represent increase risk subject 20 . Any subject participating research investigational drug device yet complete primary endpoint evaluation .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Excessive Uterine Bleeding</keyword>
	<keyword>Menorrhagia</keyword>
	<keyword>Endometrial Ablation</keyword>
</DOC>